α-methylacyl CoA racemase in pulmonary adenocarcinoma, squamous cell carcinoma, and neuroendocrine tumors: Expression and survival analysis

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 10, 2007, Pages 1555-1560

  Shilo, Konstantin ^a   Dracheva, Tatiana ^b   Mani, Haresh ^a   Fukuoka, Junya ^c   Sesterhenn, Isabell A ^a   Chu, Wei Sing ^a   Shih, Joanna H ^b   Jen, Jin ^b   Travis, William D ^d   Franks, Teri J ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c TOYAMA UNIVERSITY HOSPITAL   (Japan)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; RACEMASE;

ADULT; AGED; ARTICLE; CANCER STAGING; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FATTY ACID ANALYSIS; FATTY ACID OXIDATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; ISOMERISM; KAPLAN MEIER METHOD; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; PROGNOSIS; PROSTATE CANCER; PROTEIN EXPRESSION; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; SURVIVAL; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NEUROENDOCRINE; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RACEMASES AND EPIMERASES; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 35348991683     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ferdinandusse S, Denis S, IJIst L, et al. Subcellular localization and physiological role of α-methylacyl-CoA racemase. J Lipid Res. 2000;41:1890-1896.
2. Xu J, Stolk JA, Zhang X, et al. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res. 2000; 60:1677-1682.
3. Evans AJ. α-Methylacyl CoA racemase (P504S): overview and potential uses in diagnostic pathology as applied to prostate needle biopsies. J Clin Pathol. 2003; 56:892-897.
4. Jiang Z, Woda BA, Wu CL, et al. Discovery and clinical application of a novel prostate cancer marker: α-methylacyl CoA racemase (P504S). Am J Clin Pathol. 2004;122:275-289.
5. Jiang Z, Woda BA, Rock KL, et al. P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol. 2001;25:1397-1404.
6. Rubin MA, Zhou M, Dhanasekaran SM, et al. α-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA. 2002;287:1662-1670.
7. Luo J, Zha S, Gage WR, et al. α-Methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res. 2002;62:2220-2226.
8. Zhou M, Chinnaiyan AM, Kleer CG, Lucas PC, Rubin MA. Alpha-methyla-cyl- CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions. Am J Surg Pathol. 2002;26:926-931.
9. Yang XJ, Wu CL, Woda BA, et al. Expression of alpha-methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol. 2002;26:921-925.
10. Kuefer R, Varambally S, Zhou M, et al. α-Methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiation. Am J Pathol. 2002;161:841-848.
11. Witkiewicz AK, Varambally S, Shen R, et al. α-Methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis. Cancer Epidemiol Biomarkers Prev. 2005;14: 1418-1423.
12. Langner C, Rupar G, Leibl S, et al. Alpha-methylacyl-CoA racemase (AMACR/P504S) protein expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression. Virchows Arch. 2006;448:325-330.
13. Rubin MA, Bismar TA, Andren O, et al. Decreased α-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death. Cancer Epidemiol Biomarkers Prev. 2005;14:1424-1432.
14. Jiang Z, Fanger GR, Woda BA, et al. Expression of α-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: a study of 761 cases. Hum Pathol. 2003;34:792-796.
15. Nassar A, Amin MB, Sexton DG, et al. Utility of alpha-methylacyl coenzyme A racemase (p504s antibody) as a diagnostic immunohistochemical marker for cancer. Appl Immunohistochem Mol Morphol. 2005;13:252-255.
16. Fukuoka J, Fujii T, Shih JH, et al. Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer. Clin Cancer Res. 2004;10:4314-4324.
17. Jiang Z, Wu CL, Woda BA, et al. P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy. Am J Surg Pathol. 2002;26:1169-1174.
18. Kunju LP, Chinnaiyan AM, Shah RB. Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer. Histopathology. 2005;47:587-596.
19. Jackman DM, Johnson BE. Small-cell lung cancer. Lancet. 2005;366:1385-1396.
20. Johnson BE. Management of small cell lung cancer. Clin Chest Med. 2002; 23:225-239.
21. Zha S, Ferdinandusse S, Hicks JL, et al. Peroxisomal branched chain fatty acid beta-oxidation pathway is upregulated in prostate cancer. Prostate. 2005;63: 316-323.